Astec Lifesciences (BOM:533138) Institutional Ownership: 3.02% (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533138 Astec Lifesciences Ltd BOM:533138
71 GF Score
Price ₹719.75
GF Value ₹944.87
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Institutional Ownership?

Astec Lifesciences BOM:533138 -3.88% 71 Institutional Ownership is 3.02% as of Sep. 22, 2026. GuruFocus rates BOM:533138 with a GF Score™ of 71/100 and a GF Value™ of ₹944.87 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Astec Lifesciences's institutional ownership is 3.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Astec Lifesciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Astec Lifesciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Astec Lifesciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Institutional Ownership Chart

Astec Lifesciences Historical Data

The historical data trend for Astec Lifesciences can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 3.02 3.02 3.02 3.02 3.02 3.02 3.02 3.02 3.02 3.02
BOM:533138
71GF Score
Astec Lifesciences Ltd BOM:533138
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.02% mean?
Astec Lifesciences (BOM:533138) has a Institutional Ownership of 3.02% as of Sep. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Astec Lifesciences and its competitors.
Is Astec Lifesciences' Institutional Ownership too high?
Astec Lifesciences' current Institutional Ownership is 3.02%. Overall, Astec Lifesciences has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Institutional Ownership compare to CTVA and CF?
Astec Lifesciences' Institutional Ownership of 3.02% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for an Agriculture company?
A good Institutional Ownership depends on the Agriculture industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current Institutional Ownership is 3.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (BOM:533138) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹944.87, compared to a current price of ₹719.75 — trading 23.8% below its estimated fair value. The current Institutional Ownership is 3.02%. Astec Lifesciences' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Astec Lifesciences (BOM:533138), the current Institutional Ownership is 3.02% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (BOM:533138) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹719.75 is trading 23.8% below its estimated GF Value™ of ₹944.87. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for BOM:533138:

  • Institutional Ownership: 3.02%
  • GF Value™: ₹944.87 vs. price of ₹719.75 (23.8% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the BOM:533138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges ASTEC:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd is an Indian manufacturer of agrochemical active ingredients and pharmaceutical intermediates. The company produces fungicides, herbicides, and insecticides, along with specialty chemicals and intermediates used in pharmaceutical and other industrial applications. Its product portfolio includes triazole-based fungicides and other crop-protection actives sold to agrochemical formulators and generic manufacturers. Astec operates manufacturing facilities in India, primarily in Maharashtra, and serves both domestic and export markets, with customers in India, Europe, the Americas, and Asia. Revenue is generated through the sale of active ingredients, intermediates, and contract manufacturing services. The company was acquired by Godrej Agrovet, part of the Godrej Group, which holds a majority stake. Astec Lifesciences is listed on Indian stock exchanges.
71GF Score

Get the complete analysis for BOM:533138

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹719.75
Price
₹944.87
GF Value